[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fJWlPSX37W9F0mp2WFbjKoh7gGRIgQ3s89H27buTKp6c":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":36,"phaseBuckets":47,"rows":54},"National Center for Complementary and Integrative Health (NCCIH)",[4],222,false,8,23,41002,3,132,[14,17,20,23,25,28,31,33],{"name":15,"count":16},"HIV Infections",17,{"name":18,"count":19},"Pain",14,{"name":21,"count":22},"Depression",12,{"name":24,"count":8},"Healthy",{"name":26,"count":27},"Fibromyalgia",7,{"name":29,"count":30},"Neoplasms",6,{"name":32,"count":30},"Obesity",{"name":34,"count":35},"Cardiovascular Diseases",5,[37,42],{"nctId":38,"briefTitle":39,"date":40,"intervention":41},"NCT07549490","Human Experimental Models of Pain (HEMP)","2029-12-31","Naproxen",{"nctId":43,"briefTitle":44,"date":45,"intervention":46},"NCT07504601","Investigating the Analgesic Potential of (2R,6R)-HNK in Acute Pain in Healthy Volunteers","2030-12-31","(2R,6R)-Hydroxynorketamine",[48,49,50,51,52,53],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[55,80,101,119,166,184,202,252,284,316,340,364,388,406,430,459,477,495,548,596,624,651,673,708,734,752,770,796,814,837,855,873,891,917,935,953,976,999,1020,1044,1070,1094,1117,1139,1162,1187,1212,1236,1260,1283,1305,1323,1345,1370,1393,1417,1435,1458,1481,1505,1531,1549,1574,1599,1617,1640,1661,1679,1701,1725,1747,1769,1794,1818,1836,1854,1877,1901,1923,1944,1970,1993,2016,2037,2062,2084,2105,2130,2183,2223,2256,2280,2298,2320,2342,2368],{"intervention":46,"totalTrials":56,"cells":57},1,{"EARLY_PHASE1":58,"PHASE1":61,"PHASE2":63,"PHASE3":74,"PHASE4":76,"NA":78},{"trials":59,"activeCount":60},[],0,{"trials":62,"activeCount":60},[],{"trials":64,"activeCount":56,"soonestReadout":45},[65],{"nctId":43,"briefTitle":44,"status":66,"phases":67,"primaryCompletion":45,"completion":68,"start":69,"enrollment":70,"conditions":71,"interventions":73},"NOT_YET_RECRUITING",[50],"2031-12-31","2026-06-15",92,[72],"Healthy Volunteers",[46],{"trials":75,"activeCount":60},[],{"trials":77,"activeCount":60},[],{"trials":79,"activeCount":60},[],{"intervention":41,"totalTrials":56,"cells":81},{"EARLY_PHASE1":82,"PHASE1":84,"PHASE2":86,"PHASE3":88,"PHASE4":90,"NA":92},{"trials":83,"activeCount":60},[],{"trials":85,"activeCount":60},[],{"trials":87,"activeCount":60},[],{"trials":89,"activeCount":60},[],{"trials":91,"activeCount":60},[],{"trials":93,"activeCount":56,"soonestReadout":40},[94],{"nctId":38,"briefTitle":39,"status":66,"phases":95,"primaryCompletion":40,"completion":45,"start":69,"enrollment":96,"conditions":97,"interventions":99},[53],25,[98],"Acute Pain",[41,100],"Pregabalin",{"intervention":100,"totalTrials":56,"cells":102},{"EARLY_PHASE1":103,"PHASE1":105,"PHASE2":107,"PHASE3":109,"PHASE4":111,"NA":113},{"trials":104,"activeCount":60},[],{"trials":106,"activeCount":60},[],{"trials":108,"activeCount":60},[],{"trials":110,"activeCount":60},[],{"trials":112,"activeCount":60},[],{"trials":114,"activeCount":56,"soonestReadout":40},[115],{"nctId":38,"briefTitle":39,"status":66,"phases":116,"primaryCompletion":40,"completion":45,"start":69,"enrollment":96,"conditions":117,"interventions":118},[53],[98],[41,100],{"intervention":120,"totalTrials":11,"cells":121},"St. John's Wort",{"EARLY_PHASE1":122,"PHASE1":124,"PHASE2":126,"PHASE3":149,"PHASE4":151,"NA":164},{"trials":123,"activeCount":60},[],{"trials":125,"activeCount":60},[],{"trials":127,"activeCount":60},[128,139],{"nctId":129,"briefTitle":130,"status":131,"phases":132,"completion":133,"start":134,"enrollment":135,"conditions":136,"interventions":138},"NCT00035438","St. John's Wort Vs. Placebo in Obsessive-Compulsive Disorder.","COMPLETED",[50],"2003-09","2002-05",60,[137],"Obsessive Compulsive Disorder",[120],{"nctId":140,"briefTitle":141,"status":131,"phases":142,"completion":143,"start":144,"enrollment":145,"conditions":146,"interventions":148},"NCT00035412","St. John's Wort Versus Placebo in Social Phobia",[50],"2004-08","2001-12",40,[147],"Phobic Disorders",[120],{"trials":150,"activeCount":60},[],{"trials":152,"activeCount":60},[153],{"nctId":154,"briefTitle":155,"status":131,"phases":156,"completion":157,"start":158,"enrollment":159,"conditions":160,"interventions":161},"NCT00027014","Herb-Opioid Interactions",[52],"2005-05","2001-09",54,[18],[120,162,163],"oxycodone","fentanyl",{"trials":165,"activeCount":60},[],{"intervention":162,"totalTrials":56,"cells":167},{"EARLY_PHASE1":168,"PHASE1":170,"PHASE2":172,"PHASE3":174,"PHASE4":176,"NA":182},{"trials":169,"activeCount":60},[],{"trials":171,"activeCount":60},[],{"trials":173,"activeCount":60},[],{"trials":175,"activeCount":60},[],{"trials":177,"activeCount":60},[178],{"nctId":154,"briefTitle":155,"status":131,"phases":179,"completion":157,"start":158,"enrollment":159,"conditions":180,"interventions":181},[52],[18],[120,162,163],{"trials":183,"activeCount":60},[],{"intervention":163,"totalTrials":56,"cells":185},{"EARLY_PHASE1":186,"PHASE1":188,"PHASE2":190,"PHASE3":192,"PHASE4":194,"NA":200},{"trials":187,"activeCount":60},[],{"trials":189,"activeCount":60},[],{"trials":191,"activeCount":60},[],{"trials":193,"activeCount":60},[],{"trials":195,"activeCount":60},[196],{"nctId":154,"briefTitle":155,"status":131,"phases":197,"completion":157,"start":158,"enrollment":159,"conditions":198,"interventions":199},[52],[18],[120,162,163],{"trials":201,"activeCount":60},[],{"intervention":203,"totalTrials":11,"cells":204},"Ginkgo biloba",{"EARLY_PHASE1":205,"PHASE1":207,"PHASE2":209,"PHASE3":234,"PHASE4":248,"NA":250},{"trials":206,"activeCount":60},[],{"trials":208,"activeCount":60},[],{"trials":210,"activeCount":60},[211,223],{"nctId":212,"briefTitle":213,"status":131,"phases":214,"completion":215,"start":216,"conditions":217,"interventions":219},"NCT00010842","Natural Antioxidants in the Treatment of Multiple Sclerosis",[49,50],"2004-12","1999-09",[218],"Multiple Sclerosis",[203,220,221,222],"Alpha-lipoic acid","Vitamin E\u002FSelenium","Essential fatty acids",{"nctId":224,"briefTitle":225,"status":131,"phases":226,"completion":227,"start":228,"conditions":229,"interventions":232},"NCT00034021","Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction",[50],"2004-09","2002-06",[230,231],"Hypoactive Sexual Desire Disorder","Sexual Dysfunctions, Psychological",[233],"Ginkgo Biloba",{"trials":235,"activeCount":60},[236],{"nctId":237,"briefTitle":238,"status":131,"phases":239,"primaryCompletion":240,"completion":241,"start":242,"enrollment":243,"conditions":244,"interventions":247},"NCT00010803","Ginkgo Biloba Prevention Trial in Older Individuals",[51],"2008-04","2011-07","2000-10",3069,[245,246],"Dementia","Alzheimer's Disease",[203],{"trials":249,"activeCount":60},[],{"trials":251,"activeCount":60},[],{"intervention":253,"totalTrials":254,"cells":255},"Ginkgo Biloba Extract",2,{"EARLY_PHASE1":256,"PHASE1":258,"PHASE2":260,"PHASE3":271,"PHASE4":280,"NA":282},{"trials":257,"activeCount":60},[],{"trials":259,"activeCount":60},[],{"trials":261,"activeCount":60},[262],{"nctId":263,"briefTitle":264,"status":131,"phases":265,"completion":157,"start":144,"enrollment":266,"conditions":267,"interventions":269},"NCT00032474","Ginkgo Biloba Extract and the Insulin Resistance Syndrome",[49,50],150,[268],"Type 2 Diabetes Mellitus",[270],"Ginkgo biloba extract",{"trials":272,"activeCount":60},[273],{"nctId":274,"briefTitle":275,"status":131,"phases":276,"completion":215,"start":216,"conditions":277,"interventions":279},"NCT00010920","Preventing Cognitive Decline With Alternative Therapies",[51],[245,278],"Memory Disorders",[253],{"trials":281,"activeCount":60},[],{"trials":283,"activeCount":60},[],{"intervention":285,"totalTrials":254,"cells":286},"Echinacea",{"EARLY_PHASE1":287,"PHASE1":289,"PHASE2":291,"PHASE3":301,"PHASE4":312,"NA":314},{"trials":288,"activeCount":60},[],{"trials":290,"activeCount":60},[],{"trials":292,"activeCount":60},[293],{"nctId":294,"briefTitle":295,"status":131,"phases":296,"completion":297,"start":158,"conditions":298,"interventions":300},"NCT00032500","Evaluation of Echinacea for the Common Cold",[50],"2004-05",[299],"Common Cold",[285],{"trials":302,"activeCount":60},[303],{"nctId":304,"briefTitle":305,"status":131,"phases":306,"completion":307,"start":308,"enrollment":309,"conditions":310,"interventions":311},"NCT00029211","A Trial of Echinacea in Children",[51],"2003-03","2000-04",600,[299],[285],{"trials":313,"activeCount":60},[],{"trials":315,"activeCount":60},[],{"intervention":317,"totalTrials":56,"cells":318},"Fresh garlic or garlic supplements",{"EARLY_PHASE1":319,"PHASE1":321,"PHASE2":323,"PHASE3":325,"PHASE4":336,"NA":338},{"trials":320,"activeCount":60},[],{"trials":322,"activeCount":60},[],{"trials":324,"activeCount":60},[],{"trials":326,"activeCount":60},[327],{"nctId":328,"briefTitle":329,"status":131,"phases":330,"completion":331,"start":134,"enrollment":332,"conditions":333,"interventions":335},"NCT00056511","Comparing Effects of 3 Sources of Garlic on Cholesterol Levels",[50,51],"2005-04",220,[334],"Hypercholesterolemia",[317],{"trials":337,"activeCount":60},[],{"trials":339,"activeCount":60},[],{"intervention":341,"totalTrials":56,"cells":342},"Ethyl-eicosapentanoic acid",{"EARLY_PHASE1":343,"PHASE1":345,"PHASE2":347,"PHASE3":349,"PHASE4":360,"NA":362},{"trials":344,"activeCount":60},[],{"trials":346,"activeCount":60},[],{"trials":348,"activeCount":60},[],{"trials":350,"activeCount":60},[351],{"nctId":352,"briefTitle":353,"status":131,"phases":354,"primaryCompletion":355,"completion":355,"start":158,"enrollment":356,"conditions":357,"interventions":359},"NCT00096798","Ethyl Eicosapentanoic Acid (Ethyl-EPA) for Treating Major Depression",[51],"2007-08",80,[358,21],"Depressive Disorder",[341],{"trials":361,"activeCount":60},[],{"trials":363,"activeCount":60},[],{"intervention":365,"totalTrials":56,"cells":366},"Polyunsaturated Fatty Acids",{"EARLY_PHASE1":367,"PHASE1":369,"PHASE2":371,"PHASE3":373,"PHASE4":384,"NA":386},{"trials":368,"activeCount":60},[],{"trials":370,"activeCount":60},[],{"trials":372,"activeCount":60},[],{"trials":374,"activeCount":60},[375],{"nctId":376,"briefTitle":377,"status":131,"phases":378,"primaryCompletion":379,"completion":379,"start":133,"enrollment":135,"conditions":380,"interventions":382},"NCT00067301","PUFA Augmentation in Treatment of Major Depression",[51],"2007-04",[381],"Major Depression",[365,383],"Citalopram",{"trials":385,"activeCount":60},[],{"trials":387,"activeCount":60},[],{"intervention":383,"totalTrials":56,"cells":389},{"EARLY_PHASE1":390,"PHASE1":392,"PHASE2":394,"PHASE3":396,"PHASE4":402,"NA":404},{"trials":391,"activeCount":60},[],{"trials":393,"activeCount":60},[],{"trials":395,"activeCount":60},[],{"trials":397,"activeCount":60},[398],{"nctId":376,"briefTitle":377,"status":131,"phases":399,"primaryCompletion":379,"completion":379,"start":133,"enrollment":135,"conditions":400,"interventions":401},[51],[381],[365,383],{"trials":403,"activeCount":60},[],{"trials":405,"activeCount":60},[],{"intervention":407,"totalTrials":56,"cells":408},"Crataegus Special Extract WS 1442",{"EARLY_PHASE1":409,"PHASE1":411,"PHASE2":413,"PHASE3":415,"PHASE4":426,"NA":428},{"trials":410,"activeCount":60},[],{"trials":412,"activeCount":60},[],{"trials":414,"activeCount":60},[],{"trials":416,"activeCount":60},[417],{"nctId":418,"briefTitle":419,"status":131,"phases":420,"completion":297,"start":421,"enrollment":422,"conditions":423,"interventions":425},"NCT00343902","Hawthorn Extract Randomized Blinded Chronic Heart Failure (HERB CHF) Trial",[51],"2000-01",120,[424],"Chronic Heart Failure",[407],{"trials":427,"activeCount":60},[],{"trials":429,"activeCount":60},[],{"intervention":431,"totalTrials":56,"cells":432},"fish oil",{"EARLY_PHASE1":433,"PHASE1":435,"PHASE2":437,"PHASE3":439,"PHASE4":455,"NA":457},{"trials":434,"activeCount":60},[],{"trials":436,"activeCount":60},[],{"trials":438,"activeCount":60},[],{"trials":440,"activeCount":60},[441],{"nctId":442,"briefTitle":443,"status":444,"phases":445,"primaryCompletion":446,"completion":447,"start":448,"enrollment":449,"conditions":450,"interventions":452},"NCT00072982","Treatment of Rheumatoid Arthritis With Marine and Botanical Oils","UNKNOWN",[51],"2008-05","2008-11","2006-11",156,[451],"Rheumatoid Arthritis",[431,453,454],"borage seed oil","combination fish oil and borage seed oil",{"trials":456,"activeCount":60},[],{"trials":458,"activeCount":60},[],{"intervention":453,"totalTrials":56,"cells":460},{"EARLY_PHASE1":461,"PHASE1":463,"PHASE2":465,"PHASE3":467,"PHASE4":473,"NA":475},{"trials":462,"activeCount":60},[],{"trials":464,"activeCount":60},[],{"trials":466,"activeCount":60},[],{"trials":468,"activeCount":60},[469],{"nctId":442,"briefTitle":443,"status":444,"phases":470,"primaryCompletion":446,"completion":447,"start":448,"enrollment":449,"conditions":471,"interventions":472},[51],[451],[431,453,454],{"trials":474,"activeCount":60},[],{"trials":476,"activeCount":60},[],{"intervention":454,"totalTrials":56,"cells":478},{"EARLY_PHASE1":479,"PHASE1":481,"PHASE2":483,"PHASE3":485,"PHASE4":491,"NA":493},{"trials":480,"activeCount":60},[],{"trials":482,"activeCount":60},[],{"trials":484,"activeCount":60},[],{"trials":486,"activeCount":60},[487],{"nctId":442,"briefTitle":443,"status":444,"phases":488,"primaryCompletion":446,"completion":447,"start":448,"enrollment":449,"conditions":489,"interventions":490},[51],[451],[431,453,454],{"trials":492,"activeCount":60},[],{"trials":494,"activeCount":60},[],{"intervention":496,"totalTrials":497,"cells":498},"Silymarin",4,{"EARLY_PHASE1":499,"PHASE1":501,"PHASE2":523,"PHASE3":542,"PHASE4":544,"NA":546},{"trials":500,"activeCount":60},[],{"trials":502,"activeCount":60},[503,514],{"nctId":504,"briefTitle":505,"status":131,"phases":506,"primaryCompletion":507,"completion":508,"start":448,"enrollment":509,"conditions":510,"interventions":513},"NCT00389376","Phase I Trial of Silymarin for Chronic Liver Diseases",[49],"2008-01","2008-02",56,[511,512],"Hepatitis C","Non-Alcoholic Fatty Liver Disease",[496,496,496,496,496,496,496],{"nctId":515,"briefTitle":516,"status":131,"phases":517,"completion":518,"start":133,"enrollment":135,"conditions":519,"interventions":521},"NCT00065741","Botanical\u002FDrug Interactions in HIV: Glucuronidation",[49],"2006-03",[520],"HIV Seronegativity",[522],"silymarin",{"trials":524,"activeCount":60},[525,534],{"nctId":526,"briefTitle":527,"status":131,"phases":528,"primaryCompletion":529,"completion":529,"start":240,"enrollment":530,"conditions":531,"interventions":533},"NCT00680342","Phase II Trial of Silymarin for Patients With Chronic Hepatitis C Who Have Failed Conventional Antiviral Treatment",[50],"2011-01",154,[532],"Chronic Hepatitis C",[496,496],{"nctId":535,"briefTitle":536,"status":131,"phases":537,"completion":228,"start":538,"conditions":539,"interventions":541},"NCT00030030","Evaluating Silymarin for Chronic Hepatitis C",[50],"2000-07",[540],"Hepatitis C, Chronic",[496],{"trials":543,"activeCount":60},[],{"trials":545,"activeCount":60},[],{"trials":547,"activeCount":60},[],{"intervention":549,"totalTrials":11,"cells":550},"Black cohosh",{"EARLY_PHASE1":551,"PHASE1":553,"PHASE2":565,"PHASE3":590,"PHASE4":592,"NA":594},{"trials":552,"activeCount":60},[],{"trials":554,"activeCount":60},[555],{"nctId":556,"briefTitle":557,"status":558,"phases":559,"primaryCompletion":560,"completion":560,"start":561,"enrollment":22,"conditions":562,"interventions":564},"NCT00068185","A Study of the Pharmacokinetics of Black Cohosh","TERMINATED",[49],"2008-07","2003-08",[563],"Hot Flashes",[549],{"trials":566,"activeCount":60},[567,580],{"nctId":568,"briefTitle":569,"status":131,"phases":570,"completion":571,"start":572,"enrollment":573,"conditions":574,"interventions":576},"NCT00066144","Use of Black Cohosh and Red Clover for the Relief of Menopausal Symptoms",[50],"2006-04","2003-04",112,[563,575],"Menopause",[577,578,549,579],"Cimicifuga racemosa","Trifolium pratense","Red clover",{"nctId":581,"briefTitle":582,"status":131,"phases":583,"completion":584,"start":216,"conditions":585,"interventions":588},"NCT00010712","Effects of Black Cohosh on Menopausal Hot Flashes",[50],"2005-07",[586,563,587],"Postmenopause","Osteoporosis, Postmenopausal",[589],"Black Cohosh",{"trials":591,"activeCount":60},[],{"trials":593,"activeCount":60},[],{"trials":595,"activeCount":60},[],{"intervention":220,"totalTrials":254,"cells":597},{"EARLY_PHASE1":598,"PHASE1":600,"PHASE2":602,"PHASE3":618,"PHASE4":620,"NA":622},{"trials":599,"activeCount":60},[],{"trials":601,"activeCount":60},[],{"trials":603,"activeCount":60},[604,608],{"nctId":212,"briefTitle":213,"status":131,"phases":605,"completion":215,"start":216,"conditions":606,"interventions":607},[49,50],[218],[203,220,221,222],{"nctId":609,"briefTitle":610,"status":131,"phases":611,"primaryCompletion":612,"completion":612,"start":133,"enrollment":135,"conditions":613,"interventions":616},"NCT00079807","Painful HIV Neuropathy and Alpha-Lipoic Acid",[49,50],"2007-02",[614,615],"HIV","Peripheral Neuropathy",[617],"Alpha-Lipoic Acid",{"trials":619,"activeCount":60},[],{"trials":621,"activeCount":60},[],{"trials":623,"activeCount":60},[],{"intervention":577,"totalTrials":254,"cells":625},{"EARLY_PHASE1":626,"PHASE1":628,"PHASE2":639,"PHASE3":645,"PHASE4":647,"NA":649},{"trials":627,"activeCount":60},[],{"trials":629,"activeCount":60},[630],{"nctId":631,"briefTitle":632,"status":131,"phases":633,"completion":634,"start":635,"enrollment":636,"conditions":637,"interventions":638},"NCT00010959","Single-Dose Study of Black Cohosh and Red Clover",[49],"2002-02","2001-02",30,[575],[577,578],{"trials":640,"activeCount":60},[641],{"nctId":568,"briefTitle":569,"status":131,"phases":642,"completion":571,"start":572,"enrollment":573,"conditions":643,"interventions":644},[50],[563,575],[577,578,549,579],{"trials":646,"activeCount":60},[],{"trials":648,"activeCount":60},[],{"trials":650,"activeCount":60},[],{"intervention":578,"totalTrials":254,"cells":652},{"EARLY_PHASE1":653,"PHASE1":655,"PHASE2":661,"PHASE3":667,"PHASE4":669,"NA":671},{"trials":654,"activeCount":60},[],{"trials":656,"activeCount":60},[657],{"nctId":631,"briefTitle":632,"status":131,"phases":658,"completion":634,"start":635,"enrollment":636,"conditions":659,"interventions":660},[49],[575],[577,578],{"trials":662,"activeCount":60},[663],{"nctId":568,"briefTitle":569,"status":131,"phases":664,"completion":571,"start":572,"enrollment":573,"conditions":665,"interventions":666},[50],[563,575],[577,578,549,579],{"trials":668,"activeCount":60},[],{"trials":670,"activeCount":60},[],{"trials":672,"activeCount":60},[],{"intervention":674,"totalTrials":254,"cells":675},"Gingko Biloba",{"EARLY_PHASE1":676,"PHASE1":678,"PHASE2":680,"PHASE3":702,"PHASE4":704,"NA":706},{"trials":677,"activeCount":60},[],{"trials":679,"activeCount":60},[],{"trials":681,"activeCount":60},[682,692],{"nctId":683,"briefTitle":684,"status":131,"phases":685,"completion":584,"start":686,"enrollment":687,"conditions":688,"interventions":691},"NCT00029991","Extract of Ginkgo Biloba (EGB 761) and Vascular Function",[49,50],"2000-09",100,[689,690],"Intermittent Claudication","Peripheral Vascular Disease",[674],{"nctId":693,"briefTitle":694,"status":131,"phases":695,"completion":584,"start":686,"enrollment":696,"conditions":697,"interventions":699},"NCT00029679","Borage Oil and Ginkgo Biloba (EGb 761) in Asthma",[49,50],280,[698],"Asthma",[700,701],"Gingko biloba","Borage oil",{"trials":703,"activeCount":60},[],{"trials":705,"activeCount":60},[],{"trials":707,"activeCount":60},[],{"intervention":709,"totalTrials":56,"cells":710},"Acetaminophen",{"EARLY_PHASE1":711,"PHASE1":713,"PHASE2":715,"PHASE3":728,"PHASE4":730,"NA":732},{"trials":712,"activeCount":60},[],{"trials":714,"activeCount":60},[],{"trials":716,"activeCount":60},[717],{"nctId":718,"briefTitle":719,"status":131,"phases":720,"primaryCompletion":721,"completion":721,"start":158,"enrollment":722,"conditions":723,"interventions":725},"NCT00029770","Chiropractic Care, Medication, and Self-Care for Neck Pain",[50],"2007-05",270,[724],"Neck Pain",[709,726,727],"Non-Steroidal anti-inflammatory drugs","Tylenol with codeine",{"trials":729,"activeCount":60},[],{"trials":731,"activeCount":60},[],{"trials":733,"activeCount":60},[],{"intervention":726,"totalTrials":56,"cells":735},{"EARLY_PHASE1":736,"PHASE1":738,"PHASE2":740,"PHASE3":746,"PHASE4":748,"NA":750},{"trials":737,"activeCount":60},[],{"trials":739,"activeCount":60},[],{"trials":741,"activeCount":60},[742],{"nctId":718,"briefTitle":719,"status":131,"phases":743,"primaryCompletion":721,"completion":721,"start":158,"enrollment":722,"conditions":744,"interventions":745},[50],[724],[709,726,727],{"trials":747,"activeCount":60},[],{"trials":749,"activeCount":60},[],{"trials":751,"activeCount":60},[],{"intervention":727,"totalTrials":56,"cells":753},{"EARLY_PHASE1":754,"PHASE1":756,"PHASE2":758,"PHASE3":764,"PHASE4":766,"NA":768},{"trials":755,"activeCount":60},[],{"trials":757,"activeCount":60},[],{"trials":759,"activeCount":60},[760],{"nctId":718,"briefTitle":719,"status":131,"phases":761,"primaryCompletion":721,"completion":721,"start":158,"enrollment":722,"conditions":762,"interventions":763},[50],[724],[709,726,727],{"trials":765,"activeCount":60},[],{"trials":767,"activeCount":60},[],{"trials":769,"activeCount":60},[],{"intervention":771,"totalTrials":56,"cells":772},"High Dose Fish Oil",{"EARLY_PHASE1":773,"PHASE1":775,"PHASE2":777,"PHASE3":790,"PHASE4":792,"NA":794},{"trials":774,"activeCount":60},[],{"trials":776,"activeCount":60},[],{"trials":778,"activeCount":60},[779],{"nctId":780,"briefTitle":781,"status":131,"phases":782,"primaryCompletion":783,"completion":784,"start":446,"enrollment":785,"conditions":786,"interventions":788},"NCT00871377","Double Blind, Crossover Study of Fish Oil [EPA and DHA] for Intractable Partial Seizures",[50],"2011-05","2011-08",24,[787],"Epilepsy",[771,789],"Low Dose Fish Oil",{"trials":791,"activeCount":60},[],{"trials":793,"activeCount":60},[],{"trials":795,"activeCount":60},[],{"intervention":789,"totalTrials":56,"cells":797},{"EARLY_PHASE1":798,"PHASE1":800,"PHASE2":802,"PHASE3":808,"PHASE4":810,"NA":812},{"trials":799,"activeCount":60},[],{"trials":801,"activeCount":60},[],{"trials":803,"activeCount":60},[804],{"nctId":780,"briefTitle":781,"status":131,"phases":805,"primaryCompletion":783,"completion":784,"start":446,"enrollment":785,"conditions":806,"interventions":807},[50],[787],[771,789],{"trials":809,"activeCount":60},[],{"trials":811,"activeCount":60},[],{"trials":813,"activeCount":60},[],{"intervention":815,"totalTrials":56,"cells":816},"MAK",{"EARLY_PHASE1":817,"PHASE1":819,"PHASE2":821,"PHASE3":831,"PHASE4":833,"NA":835},{"trials":818,"activeCount":60},[],{"trials":820,"activeCount":60},[],{"trials":822,"activeCount":60},[823],{"nctId":824,"briefTitle":825,"status":131,"phases":826,"completion":143,"start":216,"enrollment":827,"conditions":828,"interventions":829},"NCT00010725","Effects of Herbal Antioxidants on Cardiovascular Disease in Older Blacks",[50],138,[34],[815,830],"Vitamin Supplements",{"trials":832,"activeCount":60},[],{"trials":834,"activeCount":60},[],{"trials":836,"activeCount":60},[],{"intervention":830,"totalTrials":56,"cells":838},{"EARLY_PHASE1":839,"PHASE1":841,"PHASE2":843,"PHASE3":849,"PHASE4":851,"NA":853},{"trials":840,"activeCount":60},[],{"trials":842,"activeCount":60},[],{"trials":844,"activeCount":60},[845],{"nctId":824,"briefTitle":825,"status":131,"phases":846,"completion":143,"start":216,"enrollment":827,"conditions":847,"interventions":848},[50],[34],[815,830],{"trials":850,"activeCount":60},[],{"trials":852,"activeCount":60},[],{"trials":854,"activeCount":60},[],{"intervention":221,"totalTrials":56,"cells":856},{"EARLY_PHASE1":857,"PHASE1":859,"PHASE2":861,"PHASE3":867,"PHASE4":869,"NA":871},{"trials":858,"activeCount":60},[],{"trials":860,"activeCount":60},[],{"trials":862,"activeCount":60},[863],{"nctId":212,"briefTitle":213,"status":131,"phases":864,"completion":215,"start":216,"conditions":865,"interventions":866},[49,50],[218],[203,220,221,222],{"trials":868,"activeCount":60},[],{"trials":870,"activeCount":60},[],{"trials":872,"activeCount":60},[],{"intervention":222,"totalTrials":56,"cells":874},{"EARLY_PHASE1":875,"PHASE1":877,"PHASE2":879,"PHASE3":885,"PHASE4":887,"NA":889},{"trials":876,"activeCount":60},[],{"trials":878,"activeCount":60},[],{"trials":880,"activeCount":60},[881],{"nctId":212,"briefTitle":213,"status":131,"phases":882,"completion":215,"start":216,"conditions":883,"interventions":884},[49,50],[218],[203,220,221,222],{"trials":886,"activeCount":60},[],{"trials":888,"activeCount":60},[],{"trials":890,"activeCount":60},[],{"intervention":892,"totalTrials":56,"cells":893},"Venlafaxine ER",{"EARLY_PHASE1":894,"PHASE1":896,"PHASE2":898,"PHASE3":911,"PHASE4":913,"NA":915},{"trials":895,"activeCount":60},[],{"trials":897,"activeCount":60},[],{"trials":899,"activeCount":60},[900],{"nctId":901,"briefTitle":902,"status":558,"phases":903,"primaryCompletion":904,"completion":143,"start":228,"enrollment":905,"conditions":906,"interventions":908},"NCT00083980","Kava Kava for the Treatment of Generalized Anxiety Disorder (GAD)",[50],"2004-06",16,[907],"Anxiety Disorders",[892,909,910],"Sugar pill","Kava",{"trials":912,"activeCount":60},[],{"trials":914,"activeCount":60},[],{"trials":916,"activeCount":60},[],{"intervention":909,"totalTrials":56,"cells":918},{"EARLY_PHASE1":919,"PHASE1":921,"PHASE2":923,"PHASE3":929,"PHASE4":931,"NA":933},{"trials":920,"activeCount":60},[],{"trials":922,"activeCount":60},[],{"trials":924,"activeCount":60},[925],{"nctId":901,"briefTitle":902,"status":558,"phases":926,"primaryCompletion":904,"completion":143,"start":228,"enrollment":905,"conditions":927,"interventions":928},[50],[907],[892,909,910],{"trials":930,"activeCount":60},[],{"trials":932,"activeCount":60},[],{"trials":934,"activeCount":60},[],{"intervention":910,"totalTrials":56,"cells":936},{"EARLY_PHASE1":937,"PHASE1":939,"PHASE2":941,"PHASE3":947,"PHASE4":949,"NA":951},{"trials":938,"activeCount":60},[],{"trials":940,"activeCount":60},[],{"trials":942,"activeCount":60},[943],{"nctId":901,"briefTitle":902,"status":558,"phases":944,"primaryCompletion":904,"completion":143,"start":228,"enrollment":905,"conditions":945,"interventions":946},[50],[907],[892,909,910],{"trials":948,"activeCount":60},[],{"trials":950,"activeCount":60},[],{"trials":952,"activeCount":60},[],{"intervention":954,"totalTrials":56,"cells":955},"Dietary Phytoestrogens",{"EARLY_PHASE1":956,"PHASE1":958,"PHASE2":960,"PHASE3":970,"PHASE4":972,"NA":974},{"trials":957,"activeCount":60},[],{"trials":959,"activeCount":60},[],{"trials":961,"activeCount":60},[962],{"nctId":963,"briefTitle":964,"status":131,"phases":965,"completion":966,"conditions":967,"interventions":969},"NCT00010686","Dietary Phytoestrogens and Bone Metabolism",[50],"2005-12",[968],"Osteoporosis",[954],{"trials":971,"activeCount":60},[],{"trials":973,"activeCount":60},[],{"trials":975,"activeCount":60},[],{"intervention":977,"totalTrials":56,"cells":978},"Black Cohosh Extract",{"EARLY_PHASE1":979,"PHASE1":981,"PHASE2":983,"PHASE3":993,"PHASE4":995,"NA":997},{"trials":980,"activeCount":60},[],{"trials":982,"activeCount":60},[],{"trials":984,"activeCount":60},[985],{"nctId":986,"briefTitle":987,"status":131,"phases":988,"completion":612,"start":989,"enrollment":990,"conditions":991,"interventions":992},"NCT00064831","Black Cohosh Extract in Postmenopausal Breast Health",[49,50],"2003-07",73,[575,563],[977],{"trials":994,"activeCount":60},[],{"trials":996,"activeCount":60},[],{"trials":998,"activeCount":60},[],{"intervention":1000,"totalTrials":56,"cells":1001},"DHEA",{"EARLY_PHASE1":1002,"PHASE1":1004,"PHASE2":1006,"PHASE3":1014,"PHASE4":1016,"NA":1018},{"trials":1003,"activeCount":60},[],{"trials":1005,"activeCount":60},[],{"trials":1007,"activeCount":60},[1008],{"nctId":1009,"briefTitle":1010,"status":131,"phases":1011,"completion":572,"start":242,"enrollment":145,"conditions":1012,"interventions":1013},"NCT00065104","Dehydroepiandrosterone Effects on HIV-1 Replication",[50],[15],[1000],{"trials":1015,"activeCount":60},[],{"trials":1017,"activeCount":60},[],{"trials":1019,"activeCount":60},[],{"intervention":1021,"totalTrials":56,"cells":1022},"Arginine",{"EARLY_PHASE1":1023,"PHASE1":1025,"PHASE2":1027,"PHASE3":1038,"PHASE4":1040,"NA":1042},{"trials":1024,"activeCount":60},[],{"trials":1026,"activeCount":60},[],{"trials":1028,"activeCount":60},[1029],{"nctId":1030,"briefTitle":1031,"status":1032,"phases":1033,"primaryCompletion":1034,"completion":1034,"start":571,"enrollment":60,"conditions":1035,"interventions":1037},"NCT00200746","Treatment of Alcohol-Related Hepatitis With Arginine","WITHDRAWN",[50],"2009-07",[1036],"Alcoholic Hepatitis",[1021],{"trials":1039,"activeCount":60},[],{"trials":1041,"activeCount":60},[],{"trials":1043,"activeCount":60},[],{"intervention":1045,"totalTrials":56,"cells":1046},"Probiotic-containing powder",{"EARLY_PHASE1":1047,"PHASE1":1049,"PHASE2":1051,"PHASE3":1064,"PHASE4":1066,"NA":1068},{"trials":1048,"activeCount":60},[],{"trials":1050,"activeCount":60},[],{"trials":1052,"activeCount":60},[1053],{"nctId":1054,"briefTitle":1055,"status":558,"phases":1056,"completion":1057,"start":584,"enrollment":636,"conditions":1058,"interventions":1063},"NCT00068094","The Effect of Good Bacteria on Nonalcoholic Fatty Liver Disease in Diabetics",[49,50],"2006-02",[1059,1060,1061,1062],"Fatty Liver","Hepatic Steatosis","Diabetes Mellitus","Liver Diseases",[1045],{"trials":1065,"activeCount":60},[],{"trials":1067,"activeCount":60},[],{"trials":1069,"activeCount":60},[],{"intervention":1071,"totalTrials":56,"cells":1072},"valerian",{"EARLY_PHASE1":1073,"PHASE1":1075,"PHASE2":1077,"PHASE3":1088,"PHASE4":1090,"NA":1092},{"trials":1074,"activeCount":60},[],{"trials":1076,"activeCount":60},[],{"trials":1078,"activeCount":60},[1079],{"nctId":1080,"briefTitle":1081,"status":131,"phases":1082,"completion":1083,"start":686,"enrollment":356,"conditions":1084,"interventions":1087},"NCT00070928","Valerian to Improve Sleep in Patients With Parkinson's Disease",[50],"2006-06",[1085,1086],"Insomnia","Parkinson's Disease",[1071],{"trials":1089,"activeCount":60},[],{"trials":1091,"activeCount":60},[],{"trials":1093,"activeCount":60},[],{"intervention":1095,"totalTrials":56,"cells":1096},"Herbal remedies",{"EARLY_PHASE1":1097,"PHASE1":1099,"PHASE2":1101,"PHASE3":1111,"PHASE4":1113,"NA":1115},{"trials":1098,"activeCount":60},[],{"trials":1100,"activeCount":60},[],{"trials":1102,"activeCount":60},[1103],{"nctId":1104,"briefTitle":1105,"status":131,"phases":1106,"completion":1107,"start":1108,"conditions":1109,"interventions":1110},"NCT00010816","Herbal Treatment of Hepatitis C in Methadone Maintained Patients",[50],"2003-06","1998-09",[511],[1095],{"trials":1112,"activeCount":60},[],{"trials":1114,"activeCount":60},[],{"trials":1116,"activeCount":60},[],{"intervention":1118,"totalTrials":56,"cells":1119},"Active liquid remedy",{"EARLY_PHASE1":1120,"PHASE1":1122,"PHASE2":1124,"PHASE3":1133,"PHASE4":1135,"NA":1137},{"trials":1121,"activeCount":60},[],{"trials":1123,"activeCount":60},[],{"trials":1125,"activeCount":60},[1126],{"nctId":1127,"briefTitle":1128,"status":131,"phases":1129,"completion":1130,"start":242,"enrollment":135,"conditions":1131,"interventions":1132},"NCT00065702","Biomarkers of Homeopathy in Fibromyalgia",[49,50],"2002-09",[26],[1118],{"trials":1134,"activeCount":60},[],{"trials":1136,"activeCount":60},[],{"trials":1138,"activeCount":60},[],{"intervention":1140,"totalTrials":56,"cells":1141},"Inosine",{"EARLY_PHASE1":1142,"PHASE1":1144,"PHASE2":1146,"PHASE3":1156,"PHASE4":1158,"NA":1160},{"trials":1143,"activeCount":60},[],{"trials":1145,"activeCount":60},[],{"trials":1147,"activeCount":60},[1148],{"nctId":1149,"briefTitle":1150,"status":131,"phases":1151,"completion":1152,"start":634,"enrollment":636,"conditions":1153,"interventions":1155},"NCT00067327","Treatment of Multiple Sclerosis Using Over the Counter Inosine",[50],"2005-09",[1154],"Multiple Sclerosis, Relapsing-Remitting",[1140],{"trials":1157,"activeCount":60},[],{"trials":1159,"activeCount":60},[],{"trials":1161,"activeCount":60},[],{"intervention":1163,"totalTrials":56,"cells":1164},"Amitriptyline",{"EARLY_PHASE1":1165,"PHASE1":1167,"PHASE2":1169,"PHASE3":1181,"PHASE4":1183,"NA":1185},{"trials":1166,"activeCount":60},[],{"trials":1168,"activeCount":60},[],{"trials":1170,"activeCount":60},[1171],{"nctId":1172,"briefTitle":1173,"status":131,"phases":1174,"primaryCompletion":904,"completion":904,"enrollment":1175,"conditions":1176,"interventions":1180},"NCT00029497","Sham Device, Pill Placebo or Treatment For Arm Pain",[50],240,[1177,1178,1179,18],"Cumulative Trauma Disorders","Repetitive Strain Injury","Carpal Tunnel Syndrome",[1163],{"trials":1182,"activeCount":60},[],{"trials":1184,"activeCount":60},[],{"trials":1186,"activeCount":60},[],{"intervention":1188,"totalTrials":56,"cells":1189},"Pycnogenol",{"EARLY_PHASE1":1190,"PHASE1":1192,"PHASE2":1194,"PHASE3":1206,"PHASE4":1208,"NA":1210},{"trials":1191,"activeCount":60},[],{"trials":1193,"activeCount":60},[],{"trials":1195,"activeCount":60},[1196],{"nctId":1197,"briefTitle":1198,"status":131,"phases":1199,"primaryCompletion":355,"completion":355,"start":561,"enrollment":1200,"conditions":1201,"interventions":1205},"NCT00064857","Pycnogenol for the Treatment of Lymphedema of the Arm in Breast Cancer Survivors",[50],26,[1202,1203,1204],"Lymphedema","Breast","Cancer",[1188],{"trials":1207,"activeCount":60},[],{"trials":1209,"activeCount":60},[],{"trials":1211,"activeCount":60},[],{"intervention":1213,"totalTrials":56,"cells":1214},"Lutein (10 or 30 mg\u002Fday)",{"EARLY_PHASE1":1215,"PHASE1":1217,"PHASE2":1219,"PHASE3":1230,"PHASE4":1232,"NA":1234},{"trials":1216,"activeCount":60},[],{"trials":1218,"activeCount":60},[],{"trials":1220,"activeCount":60},[1221],{"nctId":1222,"briefTitle":1223,"status":131,"phases":1224,"completion":1225,"start":1226,"conditions":1227,"interventions":1229},"NCT00029289","Effects of Lutein in Retinitis Pigmentosa",[49,50],"2002-10","2001-04",[1228],"Retinitis Pigmentosa",[1213],{"trials":1231,"activeCount":60},[],{"trials":1233,"activeCount":60},[],{"trials":1235,"activeCount":60},[],{"intervention":1237,"totalTrials":56,"cells":1238},"L-norleucine",{"EARLY_PHASE1":1239,"PHASE1":1241,"PHASE2":1243,"PHASE3":1254,"PHASE4":1256,"NA":1258},{"trials":1240,"activeCount":60},[],{"trials":1242,"activeCount":60},[],{"trials":1244,"activeCount":60},[1245],{"nctId":1246,"briefTitle":1247,"status":131,"phases":1248,"primaryCompletion":1249,"completion":1249,"start":1250,"enrollment":1251,"conditions":1252,"interventions":1253},"NCT00081952","Amino Acid Therapy for Hot Flashes in Postmenopausal Women",[49,50],"2007-10","2003-10",15,[563],[1237],{"trials":1255,"activeCount":60},[],{"trials":1257,"activeCount":60},[],{"trials":1259,"activeCount":60},[],{"intervention":1261,"totalTrials":56,"cells":1262},"soy isoflavones",{"EARLY_PHASE1":1263,"PHASE1":1265,"PHASE2":1267,"PHASE3":1277,"PHASE4":1279,"NA":1281},{"trials":1264,"activeCount":60},[],{"trials":1266,"activeCount":60},[],{"trials":1268,"activeCount":60},[1269],{"nctId":1270,"briefTitle":1271,"status":131,"phases":1272,"primaryCompletion":133,"completion":133,"enrollment":1273,"conditions":1274,"interventions":1276},"NCT00029796","Isoflavones and Acute-phase Response in Chronic Renal Failure",[50],52,[1275],"Kidney Failure, Chronic",[1261],{"trials":1278,"activeCount":60},[],{"trials":1280,"activeCount":60},[],{"trials":1282,"activeCount":60},[],{"intervention":1284,"totalTrials":56,"cells":1285},"Intravenous micronutrient therapy",{"EARLY_PHASE1":1286,"PHASE1":1288,"PHASE2":1290,"PHASE3":1299,"PHASE4":1301,"NA":1303},{"trials":1287,"activeCount":60},[],{"trials":1289,"activeCount":60},[],{"trials":1291,"activeCount":60},[1292],{"nctId":1293,"briefTitle":1294,"status":131,"phases":1295,"primaryCompletion":1296,"completion":1296,"start":904,"enrollment":145,"conditions":1297,"interventions":1298},"NCT00067405","Intravenous Micronutrient Therapy (IVMT) for Fibromyalgia",[49,50],"2007-07",[26],[1284],{"trials":1300,"activeCount":60},[],{"trials":1302,"activeCount":60},[],{"trials":1304,"activeCount":60},[],{"intervention":579,"totalTrials":56,"cells":1306},{"EARLY_PHASE1":1307,"PHASE1":1309,"PHASE2":1311,"PHASE3":1317,"PHASE4":1319,"NA":1321},{"trials":1308,"activeCount":60},[],{"trials":1310,"activeCount":60},[],{"trials":1312,"activeCount":60},[1313],{"nctId":568,"briefTitle":569,"status":131,"phases":1314,"completion":571,"start":572,"enrollment":573,"conditions":1315,"interventions":1316},[50],[563,575],[577,578,549,579],{"trials":1318,"activeCount":60},[],{"trials":1320,"activeCount":60},[],{"trials":1322,"activeCount":60},[],{"intervention":1324,"totalTrials":56,"cells":1325},"lipoic acid",{"EARLY_PHASE1":1326,"PHASE1":1328,"PHASE2":1330,"PHASE3":1339,"PHASE4":1341,"NA":1343},{"trials":1327,"activeCount":60},[],{"trials":1329,"activeCount":60},[],{"trials":1331,"activeCount":60},[1332],{"nctId":1333,"briefTitle":1334,"status":131,"phases":1335,"completion":1296,"start":1336,"enrollment":905,"conditions":1337,"interventions":1338},"NCT00065624","Antioxidant Functions of Lipoic Acid",[50],"2003-11",[334],[1324],{"trials":1340,"activeCount":60},[],{"trials":1342,"activeCount":60},[],{"trials":1344,"activeCount":60},[],{"intervention":1346,"totalTrials":56,"cells":1347},"Soy Isoflavone Nutritional Supplements",{"EARLY_PHASE1":1348,"PHASE1":1350,"PHASE2":1352,"PHASE3":1364,"PHASE4":1366,"NA":1368},{"trials":1349,"activeCount":60},[],{"trials":1351,"activeCount":60},[],{"trials":1353,"activeCount":60},[1354],{"nctId":1355,"briefTitle":1356,"status":131,"phases":1357,"completion":1358,"start":1359,"conditions":1360,"interventions":1363},"NCT00200824","Effects of Soy Compounds on Breast Cancer, Prostate Cancer, and Bone Health",[50],"2005-01","2000-05",[1361,1362],"Breast Cancer","Prostate Cancer",[1346],{"trials":1365,"activeCount":60},[],{"trials":1367,"activeCount":60},[],{"trials":1369,"activeCount":60},[],{"intervention":1371,"totalTrials":56,"cells":1372},"Vedic Medicine",{"EARLY_PHASE1":1373,"PHASE1":1375,"PHASE2":1377,"PHASE3":1387,"PHASE4":1389,"NA":1391},{"trials":1374,"activeCount":60},[],{"trials":1376,"activeCount":60},[],{"trials":1378,"activeCount":60},[1379],{"nctId":1380,"briefTitle":1381,"status":131,"phases":1382,"completion":1383,"start":989,"enrollment":135,"conditions":1384,"interventions":1386},"NCT00065650","Pilot Study of Vedic Medicine for Type 2 Diabetes",[50],"2004-01",[1385],"Diabetes Mellitus, Type 2",[1371],{"trials":1388,"activeCount":60},[],{"trials":1390,"activeCount":60},[],{"trials":1392,"activeCount":60},[],{"intervention":1394,"totalTrials":56,"cells":1395},"Ginseng",{"EARLY_PHASE1":1396,"PHASE1":1398,"PHASE2":1400,"PHASE3":1411,"PHASE4":1413,"NA":1415},{"trials":1397,"activeCount":60},[],{"trials":1399,"activeCount":60},[],{"trials":1401,"activeCount":60},[1402],{"nctId":1403,"briefTitle":1404,"status":131,"phases":1405,"completion":1406,"start":1407,"enrollment":135,"conditions":1408,"interventions":1409},"NCT00029692","Effects of Ginseng and Ginkgo on Drug Disposition in Man",[50],"2005-03","2002-03",[24],[1394,1410],"Ginkgo",{"trials":1412,"activeCount":60},[],{"trials":1414,"activeCount":60},[],{"trials":1416,"activeCount":60},[],{"intervention":1410,"totalTrials":56,"cells":1418},{"EARLY_PHASE1":1419,"PHASE1":1421,"PHASE2":1423,"PHASE3":1429,"PHASE4":1431,"NA":1433},{"trials":1420,"activeCount":60},[],{"trials":1422,"activeCount":60},[],{"trials":1424,"activeCount":60},[1425],{"nctId":1403,"briefTitle":1404,"status":131,"phases":1426,"completion":1406,"start":1407,"enrollment":135,"conditions":1427,"interventions":1428},[50],[24],[1394,1410],{"trials":1430,"activeCount":60},[],{"trials":1432,"activeCount":60},[],{"trials":1434,"activeCount":60},[],{"intervention":1436,"totalTrials":56,"cells":1437},"Alpha Lipoic Acid",{"EARLY_PHASE1":1438,"PHASE1":1440,"PHASE2":1442,"PHASE3":1452,"PHASE4":1454,"NA":1456},{"trials":1439,"activeCount":60},[],{"trials":1441,"activeCount":60},[],{"trials":1443,"activeCount":60},[1444],{"nctId":1445,"briefTitle":1446,"status":131,"phases":1447,"completion":143,"start":634,"enrollment":1448,"conditions":1449,"interventions":1451},"NCT00033176","Immune Restoration by Lipoic Acid in AIDS",[50],33,[1450,15],"Acquired Immunodeficiency Syndrome",[1436],{"trials":1453,"activeCount":60},[],{"trials":1455,"activeCount":60},[],{"trials":1457,"activeCount":60},[],{"intervention":1459,"totalTrials":56,"cells":1460},"herbals",{"EARLY_PHASE1":1461,"PHASE1":1463,"PHASE2":1465,"PHASE3":1475,"PHASE4":1477,"NA":1479},{"trials":1462,"activeCount":60},[],{"trials":1464,"activeCount":60},[],{"trials":1466,"activeCount":60},[1467],{"nctId":1468,"briefTitle":1469,"status":131,"phases":1470,"completion":297,"start":1471,"enrollment":1472,"conditions":1473,"interventions":1474},"NCT00029263","Screening Herbs for Drug Interactions",[50],"2001-08",140,[24],[1459],{"trials":1476,"activeCount":60},[],{"trials":1478,"activeCount":60},[],{"trials":1480,"activeCount":60},[],{"intervention":1482,"totalTrials":56,"cells":1483},"Acetylcholine",{"EARLY_PHASE1":1484,"PHASE1":1486,"PHASE2":1488,"PHASE3":1499,"PHASE4":1501,"NA":1503},{"trials":1485,"activeCount":60},[],{"trials":1487,"activeCount":60},[],{"trials":1489,"activeCount":60},[1490],{"nctId":1491,"briefTitle":1492,"status":131,"phases":1493,"completion":215,"start":1494,"enrollment":266,"conditions":1495,"interventions":1498},"NCT00001870","Study of the Effects of Vitamin C on Patients With Type 2 Diabetes",[50],"1999-01",[1496,1497],"Diabetes Mellitus, Non-Insulin Dependent","Non-Insulin Dependent",[1482],{"trials":1500,"activeCount":60},[],{"trials":1502,"activeCount":60},[],{"trials":1504,"activeCount":60},[],{"intervention":1506,"totalTrials":56,"cells":1507},"Chinese Products",{"EARLY_PHASE1":1508,"PHASE1":1510,"PHASE2":1512,"PHASE3":1525,"PHASE4":1527,"NA":1529},{"trials":1509,"activeCount":60},[],{"trials":1511,"activeCount":60},[],{"trials":1513,"activeCount":60},[1514],{"nctId":1515,"briefTitle":1516,"status":131,"phases":1517,"primaryCompletion":1518,"completion":1518,"start":1130,"enrollment":1519,"conditions":1520,"interventions":1523},"NCT00034047","Endometriosis : Traditional Medicine vs Hormone Therapy",[49,50],"2006-08",50,[1521,1522],"Endometriosis","Pelvic Pain",[1506,1524],"Nafarelin",{"trials":1526,"activeCount":60},[],{"trials":1528,"activeCount":60},[],{"trials":1530,"activeCount":60},[],{"intervention":1524,"totalTrials":56,"cells":1532},{"EARLY_PHASE1":1533,"PHASE1":1535,"PHASE2":1537,"PHASE3":1543,"PHASE4":1545,"NA":1547},{"trials":1534,"activeCount":60},[],{"trials":1536,"activeCount":60},[],{"trials":1538,"activeCount":60},[1539],{"nctId":1515,"briefTitle":1516,"status":131,"phases":1540,"primaryCompletion":1518,"completion":1518,"start":1130,"enrollment":1519,"conditions":1541,"interventions":1542},[49,50],[1521,1522],[1506,1524],{"trials":1544,"activeCount":60},[],{"trials":1546,"activeCount":60},[],{"trials":1548,"activeCount":60},[],{"intervention":1550,"totalTrials":56,"cells":1551},"creatine monohydrate",{"EARLY_PHASE1":1552,"PHASE1":1554,"PHASE2":1556,"PHASE3":1568,"PHASE4":1570,"NA":1572},{"trials":1553,"activeCount":60},[],{"trials":1555,"activeCount":60},[],{"trials":1557,"activeCount":60},[1558],{"nctId":1559,"briefTitle":1560,"status":131,"phases":1561,"completion":1562,"start":1563,"enrollment":1564,"conditions":1565,"interventions":1567},"NCT00070993","Creatine for the Treatment of Amyotrophic Lateral Sclerosis",[50],"2006-05","2002-12",110,[1566],"Amyotrophic Lateral Sclerosis",[1550],{"trials":1569,"activeCount":60},[],{"trials":1571,"activeCount":60},[],{"trials":1573,"activeCount":60},[],{"intervention":1575,"totalTrials":56,"cells":1576},"Iscar",{"EARLY_PHASE1":1577,"PHASE1":1579,"PHASE2":1581,"PHASE3":1593,"PHASE4":1595,"NA":1597},{"trials":1578,"activeCount":60},[],{"trials":1580,"activeCount":60},[],{"trials":1582,"activeCount":60},[1583],{"nctId":1584,"briefTitle":1585,"status":131,"phases":1586,"primaryCompletion":1587,"completion":1587,"start":158,"enrollment":1588,"conditions":1589,"interventions":1591},"NCT00079794","Iscar for Supplemental Care in Stage IV Lung Cancer",[50],"2004-02",36,[1590],"Lung Cancer",[1575,1592],"mistletoe",{"trials":1594,"activeCount":60},[],{"trials":1596,"activeCount":60},[],{"trials":1598,"activeCount":60},[],{"intervention":1592,"totalTrials":56,"cells":1600},{"EARLY_PHASE1":1601,"PHASE1":1603,"PHASE2":1605,"PHASE3":1611,"PHASE4":1613,"NA":1615},{"trials":1602,"activeCount":60},[],{"trials":1604,"activeCount":60},[],{"trials":1606,"activeCount":60},[1607],{"nctId":1584,"briefTitle":1585,"status":131,"phases":1608,"primaryCompletion":1587,"completion":1587,"start":158,"enrollment":1588,"conditions":1609,"interventions":1610},[50],[1590],[1575,1592],{"trials":1612,"activeCount":60},[],{"trials":1614,"activeCount":60},[],{"trials":1616,"activeCount":60},[],{"intervention":1618,"totalTrials":56,"cells":1619},"Omega-3 Fatty Acids",{"EARLY_PHASE1":1620,"PHASE1":1622,"PHASE2":1624,"PHASE3":1634,"PHASE4":1636,"NA":1638},{"trials":1621,"activeCount":60},[],{"trials":1623,"activeCount":60},[],{"trials":1625,"activeCount":60},[1626],{"nctId":1627,"briefTitle":1628,"status":131,"phases":1629,"completion":1630,"start":538,"conditions":1631,"interventions":1633},"NCT00010868","Omega-3 Fatty Acids in Bipolar Disorder",[50],"2004-07",[1632],"Bipolar Disorder",[1618],{"trials":1635,"activeCount":60},[],{"trials":1637,"activeCount":60},[],{"trials":1639,"activeCount":60},[],{"intervention":1641,"totalTrials":56,"cells":1642},"Vitamin E",{"EARLY_PHASE1":1643,"PHASE1":1645,"PHASE2":1647,"PHASE3":1655,"PHASE4":1657,"NA":1659},{"trials":1644,"activeCount":60},[],{"trials":1646,"activeCount":60},[],{"trials":1648,"activeCount":60},[1649],{"nctId":1650,"briefTitle":1651,"status":131,"phases":1652,"primaryCompletion":572,"completion":572,"enrollment":422,"conditions":1653,"interventions":1654},"NCT00010699","Effect of High Dose Vitamin E on Carotid Atherosclerosis",[50],[34],[1641],{"trials":1656,"activeCount":60},[],{"trials":1658,"activeCount":60},[],{"trials":1660,"activeCount":60},[],{"intervention":701,"totalTrials":56,"cells":1662},{"EARLY_PHASE1":1663,"PHASE1":1665,"PHASE2":1667,"PHASE3":1673,"PHASE4":1675,"NA":1677},{"trials":1664,"activeCount":60},[],{"trials":1666,"activeCount":60},[],{"trials":1668,"activeCount":60},[1669],{"nctId":693,"briefTitle":694,"status":131,"phases":1670,"completion":584,"start":686,"enrollment":696,"conditions":1671,"interventions":1672},[49,50],[698],[700,701],{"trials":1674,"activeCount":60},[],{"trials":1676,"activeCount":60},[],{"trials":1678,"activeCount":60},[],{"intervention":1680,"totalTrials":56,"cells":1681},"L-carnitine",{"EARLY_PHASE1":1682,"PHASE1":1684,"PHASE2":1686,"PHASE3":1695,"PHASE4":1697,"NA":1699},{"trials":1683,"activeCount":60},[],{"trials":1685,"activeCount":60},[],{"trials":1687,"activeCount":60},[1688],{"nctId":1689,"briefTitle":1690,"status":131,"phases":1691,"completion":143,"start":1692,"enrollment":1472,"conditions":1693,"interventions":1694},"NCT00034450","Developmental Study on Fatigue in Cancer",[50],"2002-01",[29],[1680],{"trials":1696,"activeCount":60},[],{"trials":1698,"activeCount":60},[],{"trials":1700,"activeCount":60},[],{"intervention":1702,"totalTrials":56,"cells":1703},"Creatine",{"EARLY_PHASE1":1704,"PHASE1":1706,"PHASE2":1708,"PHASE3":1719,"PHASE4":1721,"NA":1723},{"trials":1705,"activeCount":60},[],{"trials":1707,"activeCount":60},[],{"trials":1709,"activeCount":60},[1710],{"nctId":1711,"briefTitle":1712,"status":131,"phases":1713,"completion":1083,"start":1714,"enrollment":1715,"conditions":1716,"interventions":1718},"NCT00026988","Creatine Therapy for Huntington's Disease",[49,50],"2001-10",64,[1717],"Huntington's Disease",[1702],{"trials":1720,"activeCount":60},[],{"trials":1722,"activeCount":60},[],{"trials":1724,"activeCount":60},[],{"intervention":1726,"totalTrials":56,"cells":1727},"Botanicals",{"EARLY_PHASE1":1728,"PHASE1":1730,"PHASE2":1732,"PHASE3":1741,"PHASE4":1743,"NA":1745},{"trials":1729,"activeCount":60},[],{"trials":1731,"activeCount":60},[],{"trials":1733,"activeCount":60},[1734],{"nctId":1735,"briefTitle":1736,"status":131,"phases":1737,"primaryCompletion":1563,"completion":1563,"conditions":1738,"interventions":1740},"NCT00010465","Nervous System Manipulation and Botanicals for the Treatment of Recurrent Ear Infections in Children",[50],[1739],"Otitis Media",[1726],{"trials":1742,"activeCount":60},[],{"trials":1744,"activeCount":60},[],{"trials":1746,"activeCount":60},[],{"intervention":1748,"totalTrials":56,"cells":1749},"NPI-028",{"EARLY_PHASE1":1750,"PHASE1":1752,"PHASE2":1754,"PHASE3":1763,"PHASE4":1765,"NA":1767},{"trials":1751,"activeCount":60},[],{"trials":1753,"activeCount":60},[],{"trials":1755,"activeCount":60},[1756],{"nctId":1757,"briefTitle":1758,"status":1032,"phases":1759,"enrollment":60,"conditions":1760,"interventions":1762},"NCT00010907","Preliminary Human Trial of NPI-028",[50],[1761],"Alcoholism",[1748],{"trials":1764,"activeCount":60},[],{"trials":1766,"activeCount":60},[],{"trials":1768,"activeCount":60},[],{"intervention":1770,"totalTrials":56,"cells":1771},"Garlic powder standardized to allicin",{"EARLY_PHASE1":1772,"PHASE1":1774,"PHASE2":1776,"PHASE3":1788,"PHASE4":1790,"NA":1792},{"trials":1773,"activeCount":60},[],{"trials":1775,"activeCount":60},[],{"trials":1777,"activeCount":60},[1778],{"nctId":1779,"briefTitle":1780,"status":1032,"phases":1781,"primaryCompletion":1782,"completion":1782,"start":1783,"enrollment":60,"conditions":1784,"interventions":1787},"NCT00029250","Garlic in Hyperlipidemia Caused by HAART",[50],"2003-05","2001-11",[15,334,1785,1786],"Hypertriglyceridemia","Hyperglycemia",[1770],{"trials":1789,"activeCount":60},[],{"trials":1791,"activeCount":60},[],{"trials":1793,"activeCount":60},[],{"intervention":1795,"totalTrials":56,"cells":1796},"Connective Tissue Nutrient Formula",{"EARLY_PHASE1":1797,"PHASE1":1799,"PHASE2":1801,"PHASE3":1812,"PHASE4":1814,"NA":1816},{"trials":1798,"activeCount":60},[],{"trials":1800,"activeCount":60},[],{"trials":1802,"activeCount":60},[1803],{"nctId":1804,"briefTitle":1805,"status":131,"phases":1806,"completion":1630,"start":216,"conditions":1807,"interventions":1809},"NCT00010634","Complementary Naturopathic Medicine for Periodontitis",[50],[1808],"Periodontitis",[1795,1810,1811],"Adaptogenic herbs","glutamine",{"trials":1813,"activeCount":60},[],{"trials":1815,"activeCount":60},[],{"trials":1817,"activeCount":60},[],{"intervention":1810,"totalTrials":56,"cells":1819},{"EARLY_PHASE1":1820,"PHASE1":1822,"PHASE2":1824,"PHASE3":1830,"PHASE4":1832,"NA":1834},{"trials":1821,"activeCount":60},[],{"trials":1823,"activeCount":60},[],{"trials":1825,"activeCount":60},[1826],{"nctId":1804,"briefTitle":1805,"status":131,"phases":1827,"completion":1630,"start":216,"conditions":1828,"interventions":1829},[50],[1808],[1795,1810,1811],{"trials":1831,"activeCount":60},[],{"trials":1833,"activeCount":60},[],{"trials":1835,"activeCount":60},[],{"intervention":1811,"totalTrials":56,"cells":1837},{"EARLY_PHASE1":1838,"PHASE1":1840,"PHASE2":1842,"PHASE3":1848,"PHASE4":1850,"NA":1852},{"trials":1839,"activeCount":60},[],{"trials":1841,"activeCount":60},[],{"trials":1843,"activeCount":60},[1844],{"nctId":1804,"briefTitle":1805,"status":131,"phases":1845,"completion":1630,"start":216,"conditions":1846,"interventions":1847},[50],[1808],[1795,1810,1811],{"trials":1849,"activeCount":60},[],{"trials":1851,"activeCount":60},[],{"trials":1853,"activeCount":60},[],{"intervention":1855,"totalTrials":56,"cells":1856},"oyster mushroom",{"EARLY_PHASE1":1857,"PHASE1":1859,"PHASE2":1861,"PHASE3":1871,"PHASE4":1873,"NA":1875},{"trials":1858,"activeCount":60},[],{"trials":1860,"activeCount":60},[],{"trials":1862,"activeCount":60},[1863],{"nctId":1864,"briefTitle":1865,"status":131,"phases":1866,"completion":1562,"start":904,"enrollment":1867,"conditions":1868,"interventions":1870},"NCT00069524","Antihyperlipidemic Effects of Oyster Mushrooms",[49,50],20,[15,1869],"Hyperlipidemia",[1855],{"trials":1872,"activeCount":60},[],{"trials":1874,"activeCount":60},[],{"trials":1876,"activeCount":60},[],{"intervention":1878,"totalTrials":56,"cells":1879},"NucleomaxX",{"EARLY_PHASE1":1880,"PHASE1":1882,"PHASE2":1884,"PHASE3":1895,"PHASE4":1897,"NA":1899},{"trials":1881,"activeCount":60},[],{"trials":1883,"activeCount":60},[],{"trials":1885,"activeCount":60},[1886],{"nctId":1887,"briefTitle":1888,"status":131,"phases":1889,"primaryCompletion":1890,"completion":1890,"start":379,"enrollment":11,"conditions":1891,"interventions":1894},"NCT00471614","Effects of Uridine Supplementation on Metabolic Side Effects of Stavudine and Zidovudine",[50],"2012-01",[15,1892,1893],"Insulin Resistance","Hyperlactatemia",[1878],{"trials":1896,"activeCount":60},[],{"trials":1898,"activeCount":60},[],{"trials":1900,"activeCount":60},[],{"intervention":1902,"totalTrials":56,"cells":1903},"IdB 1016",{"EARLY_PHASE1":1904,"PHASE1":1906,"PHASE2":1908,"PHASE3":1917,"PHASE4":1919,"NA":1921},{"trials":1905,"activeCount":60},[],{"trials":1907,"activeCount":60},[],{"trials":1909,"activeCount":60},[1910],{"nctId":1911,"briefTitle":1912,"status":131,"phases":1913,"completion":571,"start":1336,"enrollment":1914,"conditions":1915,"interventions":1916},"NCT00055445","IdB 1016 Treatment for Hepatitis C Disease",[49,50],45,[540],[1902],{"trials":1918,"activeCount":60},[],{"trials":1920,"activeCount":60},[],{"trials":1922,"activeCount":60},[],{"intervention":1924,"totalTrials":56,"cells":1925},"Magnesium",{"EARLY_PHASE1":1926,"PHASE1":1928,"PHASE2":1930,"PHASE3":1938,"PHASE4":1940,"NA":1942},{"trials":1927,"activeCount":60},[],{"trials":1929,"activeCount":60},[],{"trials":1931,"activeCount":60},[1932],{"nctId":1933,"briefTitle":1934,"status":131,"phases":1935,"completion":1083,"start":134,"enrollment":1175,"conditions":1936,"interventions":1937},"NCT00029510","Magnesium and Asthma - Clinical Trials",[50],[698],[1924],{"trials":1939,"activeCount":60},[],{"trials":1941,"activeCount":60},[],{"trials":1943,"activeCount":60},[],{"intervention":1945,"totalTrials":56,"cells":1946},"Ginger",{"EARLY_PHASE1":1947,"PHASE1":1949,"PHASE2":1951,"PHASE3":1964,"PHASE4":1966,"NA":1968},{"trials":1948,"activeCount":60},[],{"trials":1950,"activeCount":60},[],{"trials":1952,"activeCount":60},[1953],{"nctId":1954,"briefTitle":1955,"status":131,"phases":1956,"primaryCompletion":1957,"completion":1957,"start":1107,"enrollment":1958,"conditions":1959,"interventions":1963},"NCT00065221","Ginger Control of Chemotherapy Induced Nausea and Vomiting",[50],"2007-01",180,[1960,1961,1962],"Nausea","Vomiting","Chemotherapy",[1945],{"trials":1965,"activeCount":60},[],{"trials":1967,"activeCount":60},[],{"trials":1969,"activeCount":60},[],{"intervention":1971,"totalTrials":56,"cells":1972},"Isoflavones",{"EARLY_PHASE1":1973,"PHASE1":1975,"PHASE2":1977,"PHASE3":1987,"PHASE4":1989,"NA":1991},{"trials":1974,"activeCount":60},[],{"trials":1976,"activeCount":60},[],{"trials":1978,"activeCount":60},[1979],{"nctId":1980,"briefTitle":1981,"status":131,"phases":1982,"completion":355,"start":1563,"enrollment":1983,"conditions":1984,"interventions":1986},"NCT00051402","Phytoestrogens and Memory Decline in Menopause",[50],96,[1985,586],"Memory Loss",[1971],{"trials":1988,"activeCount":60},[],{"trials":1990,"activeCount":60},[],{"trials":1992,"activeCount":60},[],{"intervention":1994,"totalTrials":56,"cells":1995},"soy protein",{"EARLY_PHASE1":1996,"PHASE1":1998,"PHASE2":2000,"PHASE3":2010,"PHASE4":2012,"NA":2014},{"trials":1997,"activeCount":60},[],{"trials":1999,"activeCount":60},[],{"trials":2001,"activeCount":60},[2002],{"nctId":2003,"briefTitle":2004,"status":131,"phases":2005,"completion":1107,"start":2006,"conditions":2007,"interventions":2009},"NCT00067678","Soy Protein in Early Diabetic Nephropathy",[49,50],"2001-07",[2008,1061],"Diabetic Nephropathy",[1994],{"trials":2011,"activeCount":60},[],{"trials":2013,"activeCount":60},[],{"trials":2015,"activeCount":60},[],{"intervention":2017,"totalTrials":56,"cells":2018},"Glucosamine Hydrochloride",{"EARLY_PHASE1":2019,"PHASE1":2021,"PHASE2":2029,"PHASE3":2031,"PHASE4":2033,"NA":2035},{"trials":2020,"activeCount":60},[],{"trials":2022,"activeCount":60},[2023],{"nctId":2024,"briefTitle":2025,"status":131,"phases":2026,"completion":1083,"start":989,"enrollment":135,"conditions":2027,"interventions":2028},"NCT00065377","Effects of Oral Glucosamine on Insulin and Blood Vessel Activity in Normal and Obese People",[49],[32,1892],[2017],{"trials":2030,"activeCount":60},[],{"trials":2032,"activeCount":60},[],{"trials":2034,"activeCount":60},[],{"trials":2036,"activeCount":60},[],{"intervention":2038,"totalTrials":56,"cells":2039},"gemcitabine hydrochloride",{"EARLY_PHASE1":2040,"PHASE1":2042,"PHASE2":2054,"PHASE3":2056,"PHASE4":2058,"NA":2060},{"trials":2041,"activeCount":60},[],{"trials":2043,"activeCount":60},[2044],{"nctId":2045,"briefTitle":2046,"status":558,"phases":2047,"completion":784,"start":2048,"enrollment":2049,"conditions":2050,"interventions":2053},"NCT00049608","Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid Tumors",[49],"2002-07",51,[1361,2051,1590,2052],"Colorectal Cancer","Pancreatic Cancer",[2038],{"trials":2055,"activeCount":60},[],{"trials":2057,"activeCount":60},[],{"trials":2059,"activeCount":60},[],{"trials":2061,"activeCount":60},[],{"intervention":2063,"totalTrials":56,"cells":2064},"Noni Extract",{"EARLY_PHASE1":2065,"PHASE1":2067,"PHASE2":2076,"PHASE3":2078,"PHASE4":2080,"NA":2082},{"trials":2066,"activeCount":60},[],{"trials":2068,"activeCount":60},[2069],{"nctId":2070,"briefTitle":2071,"status":131,"phases":2072,"completion":1083,"start":1783,"conditions":2073,"interventions":2075},"NCT00033878","Study of Noni in Cancer Patients",[49],[29,2074],"Neoplasm Metastasis",[2063],{"trials":2077,"activeCount":60},[],{"trials":2079,"activeCount":60},[],{"trials":2081,"activeCount":60},[],{"trials":2083,"activeCount":60},[],{"intervention":2085,"totalTrials":56,"cells":2086},"midazolam",{"EARLY_PHASE1":2087,"PHASE1":2089,"PHASE2":2097,"PHASE3":2099,"PHASE4":2101,"NA":2103},{"trials":2088,"activeCount":60},[],{"trials":2090,"activeCount":60},[2091],{"nctId":2092,"briefTitle":2093,"status":558,"phases":2094,"completion":1226,"start":1359,"enrollment":636,"conditions":2095,"interventions":2096},"NCT00030004","Pilot Study of Spinal Manipulation for Chronic Neck Pain",[49],[724],[2085],{"trials":2098,"activeCount":60},[],{"trials":2100,"activeCount":60},[],{"trials":2102,"activeCount":60},[],{"trials":2104,"activeCount":60},[],{"intervention":2106,"totalTrials":56,"cells":2107},"Naloxone",{"EARLY_PHASE1":2108,"PHASE1":2120,"PHASE2":2122,"PHASE3":2124,"PHASE4":2126,"NA":2128},{"trials":2109,"activeCount":60},[2110],{"nctId":2111,"briefTitle":2112,"status":131,"phases":2113,"primaryCompletion":2114,"completion":2114,"start":2115,"enrollment":2116,"conditions":2117,"interventions":2119},"NCT03096353","Sensory and Opioid Mechanisms of Affective Touch",[48],"2018-10-31","2017-08-01",29,[18,2118],"Touch",[2106],{"trials":2121,"activeCount":60},[],{"trials":2123,"activeCount":60},[],{"trials":2125,"activeCount":60},[],{"trials":2127,"activeCount":60},[],{"trials":2129,"activeCount":60},[],{"intervention":2131,"totalTrials":497,"cells":2132},"Cranberry juice",{"EARLY_PHASE1":2133,"PHASE1":2135,"PHASE2":2146,"PHASE3":2156,"PHASE4":2169,"NA":2171},{"trials":2134,"activeCount":60},[],{"trials":2136,"activeCount":60},[2137],{"nctId":2138,"briefTitle":2139,"status":131,"phases":2140,"start":215,"enrollment":2141,"conditions":2142,"interventions":2145},"NCT00093938","Cranberry Juice for Preventing Bacteria in Urine During Pregnancy",[49],360,[2143,2144],"Urinary Tract Infection","Bacteriuria",[2131],{"trials":2147,"activeCount":60},[2148],{"nctId":2149,"briefTitle":2150,"status":444,"phases":2151,"primaryCompletion":2152,"completion":2152,"start":721,"enrollment":2153,"conditions":2154,"interventions":2155},"NCT00100061","Effects of Cranberry-Containing Products in Women With Recurrent Urinary Tract Infections (UTIs)",[50],"2013-07",350,[2143],[2131],{"trials":2157,"activeCount":60},[2158],{"nctId":2159,"briefTitle":2160,"status":131,"phases":2161,"primaryCompletion":2162,"completion":2163,"start":2164,"enrollment":2165,"conditions":2166,"interventions":2168},"NCT00093054","Cranberry Juice for Treatment of Urinary Tract Infections",[50,51],"2008-03","2009-12","2004-11",319,[2167],"Urinary Tract Infections",[2131],{"trials":2170,"activeCount":60},[],{"trials":2172,"activeCount":60},[2173],{"nctId":2174,"briefTitle":2175,"status":131,"phases":2176,"completion":2177,"start":2178,"enrollment":2179,"conditions":2180,"interventions":2181},"NCT00084201","Interactions Between Cranberry Juice and Antibiotics Used to Treat Urinary Tract Infections",[53],"2007-06","2006-07",18,[2167],[2131,2182],"Amoxicillin",{"intervention":2184,"totalTrials":11,"cells":2185},"Hypericum perforatum",{"EARLY_PHASE1":2186,"PHASE1":2188,"PHASE2":2190,"PHASE3":2201,"PHASE4":2211,"NA":2213},{"trials":2187,"activeCount":60},[],{"trials":2189,"activeCount":60},[],{"trials":2191,"activeCount":60},[2192],{"nctId":2193,"briefTitle":2194,"status":131,"phases":2195,"completion":448,"start":2196,"enrollment":2197,"conditions":2198,"interventions":2200},"NCT00100295","Herbal Treatment for Attention Deficit Hyperactivity Disorder (ADHD)",[50],"2005-02",59,[2199],"Attention Deficit Hyperactivity Disorder",[2184],{"trials":2202,"activeCount":60},[2203],{"nctId":2204,"briefTitle":2205,"status":131,"phases":2206,"completion":1083,"start":2207,"enrollment":509,"conditions":2208,"interventions":2210},"NCT00118833","St. John's Wort for the Treatment of Generalized Social Anxiety Disorder (GSAD)",[50,51],"2002-08",[907,2209],"Mental Health",[2184],{"trials":2212,"activeCount":60},[],{"trials":2214,"activeCount":60},[2215],{"nctId":2216,"briefTitle":2217,"status":131,"phases":2218,"completion":1383,"start":1692,"enrollment":96,"conditions":2219,"interventions":2221},"NCT00026013","Effects of St. John's Wort on the Effectiveness of Oral Contraceptives",[53],[2220],"Contraception",[2222],"hypericum perforatum",{"intervention":2224,"totalTrials":254,"cells":2225},"Cranberry juice cocktail",{"EARLY_PHASE1":2226,"PHASE1":2228,"PHASE2":2230,"PHASE3":2242,"PHASE4":2244,"NA":2246},{"trials":2227,"activeCount":60},[],{"trials":2229,"activeCount":60},[],{"trials":2231,"activeCount":60},[2232],{"nctId":2233,"briefTitle":2234,"status":131,"phases":2235,"primaryCompletion":2236,"completion":2237,"start":2238,"enrollment":2239,"conditions":2240,"interventions":2241},"NCT00128128","Cranberry Juice for the Prevention of Recurrent Urinary Tract Infections",[50],"2008-12","2009-06","2005-08",176,[2167],[2224],{"trials":2243,"activeCount":60},[],{"trials":2245,"activeCount":60},[],{"trials":2247,"activeCount":60},[2248],{"nctId":2249,"briefTitle":2250,"status":131,"phases":2251,"completion":2252,"start":2253,"enrollment":35,"conditions":2254,"interventions":2255},"NCT00087828","Identification of the Cranberry Juice Compounds That Prevent Urinary Tract Infections",[53],"2005-06","2000-11",[2167],[2224],{"intervention":2257,"totalTrials":56,"cells":2258},"Chromium picolinate",{"EARLY_PHASE1":2259,"PHASE1":2261,"PHASE2":2263,"PHASE3":2265,"PHASE4":2267,"NA":2269},{"trials":2260,"activeCount":60},[],{"trials":2262,"activeCount":60},[],{"trials":2264,"activeCount":60},[],{"trials":2266,"activeCount":60},[],{"trials":2268,"activeCount":60},[],{"trials":2270,"activeCount":60},[2271],{"nctId":2272,"briefTitle":2273,"status":131,"phases":2274,"completion":966,"start":1383,"enrollment":135,"conditions":2275,"interventions":2279},"NCT00128154","Chromium Picolinate for the Treatment of Metabolic Syndrome",[53],[2276,2277,1892,32,2278],"Metabolic Syndrome X","Prediabetic State","Metabolic Diseases",[2257],{"intervention":2182,"totalTrials":56,"cells":2281},{"EARLY_PHASE1":2282,"PHASE1":2284,"PHASE2":2286,"PHASE3":2288,"PHASE4":2290,"NA":2292},{"trials":2283,"activeCount":60},[],{"trials":2285,"activeCount":60},[],{"trials":2287,"activeCount":60},[],{"trials":2289,"activeCount":60},[],{"trials":2291,"activeCount":60},[],{"trials":2293,"activeCount":60},[2294],{"nctId":2174,"briefTitle":2175,"status":131,"phases":2295,"completion":2177,"start":2178,"enrollment":2179,"conditions":2296,"interventions":2297},[53],[2167],[2131,2182],{"intervention":2299,"totalTrials":56,"cells":2300},"chamomile tea",{"EARLY_PHASE1":2301,"PHASE1":2303,"PHASE2":2305,"PHASE3":2307,"PHASE4":2309,"NA":2311},{"trials":2302,"activeCount":60},[],{"trials":2304,"activeCount":60},[],{"trials":2306,"activeCount":60},[],{"trials":2308,"activeCount":60},[],{"trials":2310,"activeCount":60},[],{"trials":2312,"activeCount":60},[2313],{"nctId":2314,"briefTitle":2315,"status":131,"phases":2316,"completion":904,"start":1108,"conditions":2317,"interventions":2319},"NCT00010933","Treatment of Functional Abdominal Pain in Children: Evaluation of Relaxation\u002FGuided Imagery and Chamomile Tea as Therapeutic Modalities",[53],[2318],"Recurrent Abdominal Pain",[2299],{"intervention":2321,"totalTrials":56,"cells":2322},"antioxidants",{"EARLY_PHASE1":2323,"PHASE1":2325,"PHASE2":2327,"PHASE3":2329,"PHASE4":2331,"NA":2333},{"trials":2324,"activeCount":60},[],{"trials":2326,"activeCount":60},[],{"trials":2328,"activeCount":60},[],{"trials":2330,"activeCount":60},[],{"trials":2332,"activeCount":60},[],{"trials":2334,"activeCount":60},[2335],{"nctId":2336,"briefTitle":2337,"status":131,"phases":2338,"completion":215,"start":216,"conditions":2339,"interventions":2341},"NCT00010881","Oregon Center for Complementary and Alternative Medicine in Neurological Disorders",[53],[2340],"Neurological Disorders",[2321],{"intervention":2343,"totalTrials":56,"cells":2344},"Glucosamine",{"EARLY_PHASE1":2345,"PHASE1":2347,"PHASE2":2349,"PHASE3":2351,"PHASE4":2353,"NA":2355},{"trials":2346,"activeCount":60},[],{"trials":2348,"activeCount":60},[],{"trials":2350,"activeCount":60},[],{"trials":2352,"activeCount":60},[],{"trials":2354,"activeCount":60},[],{"trials":2356,"activeCount":60},[2357],{"nctId":2358,"briefTitle":2359,"status":131,"phases":2360,"completion":2361,"start":2362,"enrollment":2363,"conditions":2364,"interventions":2366},"NCT00086229","Absorption and Distribution of Glucosamine and Chondroitin",[53],"2006-01","2004-04",70,[2365],"Osteoarthritis",[2343,2367],"Chondroitin",{"intervention":2367,"totalTrials":56,"cells":2369},{"EARLY_PHASE1":2370,"PHASE1":2372,"PHASE2":2374,"PHASE3":2376,"PHASE4":2378,"NA":2380},{"trials":2371,"activeCount":60},[],{"trials":2373,"activeCount":60},[],{"trials":2375,"activeCount":60},[],{"trials":2377,"activeCount":60},[],{"trials":2379,"activeCount":60},[],{"trials":2381,"activeCount":60},[2382],{"nctId":2358,"briefTitle":2359,"status":131,"phases":2383,"completion":2361,"start":2362,"enrollment":2363,"conditions":2384,"interventions":2385},[53],[2365],[2343,2367]]